Literature DB >> 19918898

Lack of quadriceps dysfunction in women with early knee osteoarthritis.

Abbey C Thomas1, Maryfran Sowers, Carrie Karvonen-Gutierrez, Riann M Palmieri-Smith.   

Abstract

Quadriceps dysfunction, specifically weakness and central activation failure (CAF), has been implicated in the development and progression of knee osteoarthritis (OA), though few data are available to confirm its presence in early OA. The purpose of this study was to determine the presence and magnitude of quadriceps dysfunction in those with and without early knee OA. Thirty-five female volunteers were classified into two groups, OA (n=22) and control (n=13), based on the presence [Kellgren-Lawrence (K-L) grade 2] or absence (K-L grade 0-1) of mild OA, respectively. Isometric quadriceps strength and central activation ratio (CAR) were assessed and compared between groups utilizing a one-way ANOVA. Frequency statistics and Fisher's exact test were used to compare the percentage of women with and without CAF between groups. Quadriceps strength (control: 1.47+/-0.62 Nm/kg; OA: 1.30+/-0.62 Nm/kg; p=0.45) was not significantly different for women with and without mild OA. Further, the CAR (control: 0.91+/-0.07; OA: 0.87+/-0.12; p=0.19) did not differ between groups; however, women in both groups presented with CAF (control: 54%; OA: 73%; p=0.29). Our results suggest that the women with mild osteoarthritis do not present with quadriceps dysfunction. Copyright (c) 2009 Orthopaedic Research Society.

Entities:  

Mesh:

Year:  2010        PMID: 19918898     DOI: 10.1002/jor.21038

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  9 in total

Review 1.  Non-surgical management of early knee osteoarthritis.

Authors:  Elizaveta Kon; Giuseppe Filardo; Matej Drobnic; Henning Madry; Mislav Jelic; Niek van Dijk; Stefano Della Villa
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-25       Impact factor: 4.342

Review 2.  The evolving role of obesity in knee osteoarthritis.

Authors:  MaryFran R Sowers; Carrie A Karvonen-Gutierrez
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

3.  Quadriceps muscle activation and radiographic osteoarthritis following ACL revision.

Authors:  Joseph M Hart; Kimberly A Turman; David R Diduch; Jennifer A Hart; Mark D Miller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-11-26       Impact factor: 4.342

4.  Contralateral effects of disinhibitory tens on quadriceps function in people with knee osteoarthritis following unilateral treatment.

Authors:  Brian G Pietrosimone; Susan A Saliba; Joseph M Hart; Jay Hertel; Christopher D Ingersoll
Journal:  N Am J Sports Phys Ther       Date:  2010-09

5.  Muscle impairments in patients with knee osteoarthritis.

Authors:  Ali H Alnahdi; Joseph A Zeni; Lynn Snyder-Mackler
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

6.  Knee power is an important parameter in understanding medial knee joint load in knee osteoarthritis.

Authors:  Kristina M Calder; Stacey M Acker; Neha Arora; Karen A Beattie; Jack P Callaghan; Jonathan D Adachi; Monica R Maly
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-05       Impact factor: 4.794

7.  Electromyographic activity of quadriceps muscle during sit-to-stand in patients with unilateral knee osteoarthritis.

Authors:  Hamad S Al Amer; Mohamed A Sabbahi; Hesham N Alrowayeh; William J Bryan; Sharon L Olson
Journal:  BMC Res Notes       Date:  2018-06-05

8.  Double-Bundle Anterior Cruciate Ligament Reconstruction Using Hamstring Tendon Hybrid Grafts in Patients Over 40 Years of Age: Comparisons Between Different Age Groups.

Authors:  Yusuke Nishio; Eiji Kondo; Jun Onodera; Tomohiro Onodera; Tomonori Yagi; Norimasa Iwasaki; Kazunori Yasuda
Journal:  Orthop J Sports Med       Date:  2018-05-24

9.  Balance and gait adaptations in patients with early knee osteoarthritis.

Authors:  Lynsey D Duffell; Dominic F L Southgate; Vivek Gulati; Alison H McGregor
Journal:  Gait Posture       Date:  2014-01-19       Impact factor: 2.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.